General
Preferred name
BEVONIUM
Synonyms
Bevonium metilsulfate ()
CG201 ()
Bevonium methylsulfate ()
Bevonium cation ()
Bevonium ion ()
Acabel ()
Bevonium metilsulphate ()
Bevonium methylsulphate ()
Piribenzil methylsulfate ()
Bevonium methyl sulfate ()
CG-201 ()
Piribenzyl methylsulfate ()
CG 201 ()
P&D ID
PD013813
CAS
33371-53-8
5205-82-3
Tags
available
drug candidate
drug
Drug indication
Solid tumour/cancer
Drug Status
experimental
approved
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Bevonium methylsulfate (CG-201) is an injection that stimulates antibodies to block the pathological forms of hCG that help cancer cells grow and evade the immune system. CG201 was originally created in collaboration with the World Health Organization as a low-cost contraceptive method for developing countries. CG201 is now approved for a Phase I clinical trial in Sweden.
(BOC Sciences Bioactive Compounds)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
8
BOC Sciences Bioactive Compounds
ChEMBL Drugs
DrugBank
DrugCentral
DrugCentral Approved Drugs
DrugMAP
NPC Screening Collection
ReFrame library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
28
Molecular Weight
354.21
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
1
Rotatable Bonds
5
Ring Count
3
Aromatic Ring Count
2
cLogP
3.09
TPSA
46.53
Fraction CSP3
0.41
Chiral centers
1.0
Largest ring
6.0
QED
0.66
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Solubility
Soluble in Methanol (Slightly), Water (Slightly)
Source data
